Clinical trials
Pemphigoid, Benign Mucous Membrane trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Unknown status | 3 |
| Available | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| IRCCS Ospedale San Raffaele | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| James Chodosh, MD, MPH | 1 |
| Joseph B. Ciolino, MD | 1 |
| Massachusetts Eye and Ear Infirmary | 1 |
| National Taiwan University Hospital | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pemphigoid, Benign Mucous Membrane | 16 |
| Stevens-Johnson Syndrome | 5 |
| Pemphigus | 4 |
| Autoimmune Diseases | 2 |
| Blindness | 2 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Lichen Planus, Oral | 2 |
| Limbal Stem Cell Deficiency | 2 |
| Albinism | 1 |
| Aniridia | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.